Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products

Applied Clay Science

Volumn 36, Issue 1-3, 2007, Pages 51-63

  Lopez Galindo A ^a   Viseras, C ^b   Cerezo, P ^b  

^a INSTITUTO ANDALUZ DE CIENCIAS DE LA TIERRA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Clay; Cosmetic; Excipient; Pharmaceutical; Specification

Indexed keywords

CLAY MINERALS; DRUG PRODUCTS; HEALTH RISKS; RHEOLOGY; SPECIFICATIONS;

COSMETIC PRODUCTS; EXCIPIENT;

CLAY;

CHEMICAL COMPOSITION; CLAY MINERAL; DRUG; MINERALIZATION;

EID: 33947167158     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2006.06.016     Document Type: Article

References (92)

1. Adamis Z., and Williams R.B. Bentonite, kaolin, and selected clay minerals. Environmental Health Criteria. World Health Organization Library vol. 231 (2005), Cataloguing-in-Publication Data, Geneve
2. Aguzzi C., Cerezo P., Viseras C., and Caramella C. Use of clays as drug delivery systems: Possibilities and limitations. Appl. Clay Sci. 36 (2007) 22-36 10.1016/j.clay.2006.06.015 (this volume)
3. Anonymous. The silicates: attapulgite, kaolin, kieselguhr, magnesium trisilicate, pumice, talc. Int. J. Pharm. Compd. 2 2 (1998) 162-163
4. Anonymous. Annual review of cosmetic ingredient safety assessments - 2001/2002. Int. J. Toxicol. 22 Suppl. 1 (2003) 1-35
5. Anthony J.W., Bideaux R.A., Bladh K.W., and Nichols M.C. Handbook of Mineralogy vol. II (1995), Silica, Silicates, Mineral Data Publishing, Tucson, Arizona
6. Baris Y.I., Sahin A.A., and Erkan M.L. Clinical and radiological study in sepiolite workers. Arch. Environ. Health 35 (1980) 343-346
7. Be'gin R., Masse' S., Rola-Pleszcynski M., Geoffroy M., Martel M., Desmarais Y., and Sebastien P. The lung biological activity of American attapulgite. Environ. Res. 42 (1987) 328-339
8. Bellmann B., Muhle H., and Ernst H. Investigations on health-related properties of two sepiolite samples. Environ. Health Perspect. 105 Suppl. 5 (1997) 1049-1052
9. Blount A.M. Amphibole content of cosmetic ant pharmaceutical talcs. Environ. Health Perspect. 94 (1991) 225-230
10. Blount A.M., and Vassiliou A.H. Identification of chlorite and serpentine in cosmetic or pharmaceutical talc. Environ. Health Perspect. 51 (1983) 379-385
11. In: Braun D.B. (Ed). Over the Counter Pharmaceutical Formulations (1994), Noyes Publications, New Jersey
12. British Pharmacopoeia, 2004. The Stationery Office, London.
13. Bubik J.S. Preparation of sterile talc for treatment of pleural effusion. Am. J. Hosp. Pharm. 49 (1992) 562-563
14. Canadian Centre for Occupational Health and Safety (web page): http://search.ccinfoweb.ccohs.ca/ccohs/jsp/search/search.jsp?MaxDocs=500 &ResultStart=1&SortSpec=Score%2520desc&hideTabs=F&hTab=7 &vTab=1&QueryText=sepiolite&ResultsCount=20.
15. Carr C.F. Talc: consumer uses and health perspectives. Regul. Toxicol. Pharmacol. 21 (1995) 211-215
16. Carretero M.I. Clay minerals and their beneficial effects upon human health. A review. Appl. Clay Sci. 21 (2002) 155-163
17. Cerezo, P., 2003. Mecanismos y cinéticas de adsorción-liberación de fármacos en soporte arcilloso. Contribución al estudio de complejos timolol maleato con esmectitas, paligorskitas y sepiolitas. Ph. D. Thesis, Univ. Granada. 669 pp.
18. Comparative Toxicogenomics Database (web page): http://ctd.mdibl.org/voc.go;jsessionid=E3030A3BBB2E7037243DAF4112A1B506? voc=chem and termUI=magnesium+trisilicate.
19. Cornejo J. Las arcillas en formulaciones farmacéuticas. In: Galán E., and Ortega M. (Eds). Conferencias de la IX y X Reuniones de la Sociedad Española de Arcillas (1990) 51-68
20. Cramer D.W., Liberman R.F., Titus-Ernstoff L., Welch W.R., Greenberg E.R., Baron J.A., and Harlow B.L. Genital talc exposure and risk of ovarian cancer. Int. J. Cancer 81 3 (1999) 351-356
21. De la Rosa M.C., Medina M.R., and Vivar C. Microbiological quality of pharmaceutical raw materials. Pharm. Acta Helv. 70 (1995) 227-232
22. Elmore A.R. Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, Fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite. Int. J. Toxicol. 22 Suppl. 1 (2003) 37-102
23. European Comission, Decision 96/335/EC. Inventory of ingredients used in cosmetic products, alfabetic by INCI name. Available at http://europa.eu.int/comm/enterprise/cosmetics/inci/incialf.htm.
24. European Pharmacopoeia 4th Edition, 2002. European Pharmacopoeia Convention, Strasbourg, France. Aluminium magnesium silicate, 621-623; Bentonite, 707-708; Kaolin, heavy, 1429; Magnesium trisilicate, 1518; Talc, 1999-2000.
25. Evans A.M. Ore geology and industrial minerals. An Introduction (1993), Blackwell Science 389 pp.
26. FDA. Frequency of Use of Cosmetic Ingredients. FDA Database (2001), Food and Drug Administration, Washington, DC
27. Galan E., and Carretero M.I. A new approach to compositional limits for sepiolite and palygorskite. Clays Clay Miner. 47 4 (1999) 399-409
28. Galán E., Liso M.J., and Forteza M. Minerales utilizados en la industria farmacéutica. Bol. Soc. Esp. Mineral. 8 (1985) 369-378
29. Gamiz E., Linares J., and Delgado R. Assessment of two Spanish bentonites for pharmaceutical uses. Appl. Clay Sci. 6 5-6 (1992) 359-368
30. Gilbertson W.E. The regulatory status of talc. Regul. Toxicol. Pharmacol. 21 (1995) 230-232
31. Governa M., Valentino M., Visonà I., Monaco F., Amati M., Scancarello G., and Scansetti G. In vitro biological effects of clay minerals advised as substitutes for asbestos. Cell Biol. Toxicol. 11 (1995) 237-249
32. Guthrie G.D. Biological effects of inhaled minerals. Am. Mineral. 77 3-4 (1992) 225-243
33. Harlow B.L., and Hartge P. A review of perineal talc exposure and risk of ovarian cancer. Regul. Toxicol. Pharmacol. 21 (1995) 254-260
34. Harlow B.L., Cramer D.W., Bell D.A., and Welch W.R. Perineal exposure to talc and ovarian cancer risk. Obstet. Gynecol. 80 (1992) 19-26
35. Harben P.W. The industrial minerals handybook - A guide to markets, specifications and prices. 4th ed. (2002), Industrial Minerals Information Services, Worcester Park, UK 412
36. Health and Safety Executive. EH40/2002. Occupational Exposure Limits. Sudbury.
37. IARC Summaries and Evaluation. Talc 42 (1987) (185 and 349)
38. IARC Summaries and Evaluation, 1997a. Silica. Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Scientific Publications, Lyon, France. 68, p.41.
39. IARC Summaries and Evaluation. Palygorskite (Attapulgite). Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 68 (1997), IARC Scientific Publications, Lyon, France 245
40. IARC Summaries and Evaluation. Sepiolite. Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 68 (1997), IARC Scientific Publications, Lyon, France 267
41. IARC. Carbon black, titanium dioxide and non-asbestiform talc. Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 93 (2006)
42. Jaurand M.C., Fleury J., Monchaux G., Nebut M., and Bignon J. Pleural carcinogenic potency of mineral fibers asbestos attapulgite and their cytotoxicity in cultured cells. J. Natl. Cancer Inst. 79 (1987) 797-804
43. In: Kendall T. (Ed). Industrial Clays (1996), Industrial Minerals Information Ltd., London 78 pp.
44. Kibbe A.H. Handbook of Pharmaceutical Excipients. 3rd ed. (2000), American Pharmaceutical Association, Washington, DC
45. Kogel J.E., and Lewis S.A. Baseline studies of the clay minerals society source clays: chemical analysis by inductively coupled plasma-mass spectroscopy (ICP-MS). Clays Clay Miner. 49 5 (2001) 387-392
46. Konta J. Clay and man: clay raw materials in the service of man. Appl. Clay Sci. 10 (1995) 275-335
47. Lagaly G. Principles of flow of kaolin and bentonite dispersions. Appl. Clay Sci. 4 (1989) 105-123
48. Laurin P., Nguyen N., L'Esperance G., and Tawashi R. Effect of particle morphology on the hiding power of talc powder. Int. J. Pharm. 28 2-3 (1986) 177-182
49. Lin K., and Peck G.E. Characterization of talc samples from different sources. Drug Dev. Ind. Pharm. 20 (1994) 2993-3003
50. Lipson S.M., and Stotzky G. Adsorption of reovirus to clay minerals: effects of cation-exchange capacity, cation saturation, and surface area. Appl. Environ. Microbiol. 46 (1983) 673-682
51. López-Galindo A., and Sánchez-Navas A. Criterios morfológicos, cristalográficos y geoquímicos de diferenciación entre sepiolitas de origen sedimentario e hidrotermal. Bol. Soc. Esp. Mineral. 12 (1989) 375-384
52. López-Galindo A., and Viseras C. Pharmaceutical and cosmetic applications of clays. In: Wypych F., and Satyanarayana K.G. (Eds). Clay Surfaces: Fundamentals and Applications (2004), Elsevier, Armsterdam 267-289
53. Love R.G., Waclawski E.R., Maclaren W.M., Wetherill G.Z., Groat S.K., Porteous R.H., and Soutar C.A. Risks of respiratory disease in the heavy clay industry. Occup. Environ. Med. 56 2 (1999) 124-133
54. Mascolo N., Summa V., and Tateo F. Characterization of toxic elements in clays for human healing use. Appl. Clay Sci. 15 (1999) 491-500
55. Mascolo N., Summa V., and Tateo F. In vivo experimental data on the mobility of hazardous chemical elements from clays. Appl. Clay Sci. 25 (2004) 23-28
56. McConnochie K., Bevan C., Newcombe R.G., Lyons J.P., Skidmore W.J., and Wagner J.C. A study of Spanish sepiolite workers. Thorax 48 (1993) 370-374
57. Meunier A. Clays (2005), Springer, Heidelberg 472 pp.
58. Murray H.H. Traditional and new applications for kaolin, smectite, and palygorskite: a general overview. Appl. Clay Sci. 17 (2000) 207-221
59. Murray H.H., and Keller W.D. Kaolins, kaolins and kaolins. In: Murray H., Bundy W., and Harvey C. (Eds). Kaolin: Genesis and utilization (1993), Clay Minerals Society, Boulder, Colorado 1-24
60. Newman A.C.D., and Brown G. The chemical constitution of clays. In: Newman A.C.D. (Ed). Chemistry of Clays and Clay Minerals. Mineralogical Society Monograph No. 6 (1987), Wiley-Interscience, New York
61. In: Nikitakis J.M., and McEwen Jr. G.N. (Eds). CTFA Compendium of Cosmetic Ingredient Composition-Specifications (1990), Toiletry and Fragance Association, Washington, DC
62. Nolan R.P., Langer A.M., and Herson G.B. Characterisation of palygorskite specimens from different geological locales for health hazard evaluation. Br. J. Ind. Med. 48 7 (1991) 463-475
63. Piniazkiewicz R.J., McCarthy E.F., and Genco N.A. Talc. In: Carr D.D. (Ed). Industrial Minerals and Rocks. 6th ed. (1994), Society of Mining, Metallurgy and Exploration, Littleton, CO 1049-1069
64. Pott F., Ziem U., Reiffer F.J., Huth F., Ernst H., and Mohr U. Carcinogenicity studies on fibers, metal compounds, and some other dusts in rats. Exp. Pathol. 32 (1987) 129-152
65. Rempe J.L., and Santucci L.G. CTFA List of Japanese Cosmetic Ingredients. 3rd ed. (1998), Toiletry and Fragance Association, Washington, DC
66. Rohl A.N., Langer A.M., Selikoff I.J., Tordini A., Klimentidis R., Bowes D.R., and Skinner D.R. Consumer talcums and powders: mineral and chemical characterization. J. Toxicol. Environ. Health 2 2 (1976) 255-284
67. Rowe, R.C., Sheskey, P.J., Weller, P.J., (Eds.), 2003. Handbook of Pharmaceutical Excipients. 4th ed. Pharmaceutical Press and the American Pharmaceutical Association.
68. Rowe R.C., Shesley P.J., and Owen S.C. Pharmaceutical Excipients (2006), Pharmaceutical Press, London. http://www.medicinescomplete.com/mc/excipients/current/ Electronic version Available at: http://www.medicinescomplete.com/mc/excipients/current/
69. Russell M. Microbiological control of raw materials. In: Bloomfield S.F., Baird R., Lear R.E., and Leech R. (Eds). Microbial quality assurance in Pharmaceuticals, Cosmetics and Toiletries (1988), Ellis Horwood, Chichester 35-48
70. Schiffenbauer M., and Stotzky G. Adsorption of coliphages T1 and T7 to clay minerals. Appl. Environ. Microbiol. 43 (1982) 590-596
71. Soriano M., Delgado G., Gámiz E., Sánchez-Marañón M., and Delgado R. Mineralogy of pharmaceutical formulations: talcum powder from Europe and America. Ars Pharm. 37 2 (1996) 293-300
72. Soriano M., Melgosa M., Sánchez-Marañón M., Delgado G., Gámiz E., and Delgado R. Whiteness of talcum powders as a quality index for pharmaceutical uses. Color Res. Appl. 23 3 (1998) 178-185
73. Stanton M.F., Layard M., Tegeris A., Miller E., May M., and Morgan E. Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J. Natl. Cancer Inst. 67 (1981) 965-975
74. In: Sweetman S. (Ed). Martindale: The Complete Drug Reference (2006), Pharmaceutical Press, London. http://www.medicinescomplete.com/mc/martindale/current/ Electronic version available at: http://www.medicinescomplete.com/mc/martindale/current/
75. Tateo F., Summa V., Bonelli C.G., and Bentivenga G. Mineralogy and geochemistry of herbalist's clays for internal use: simulation of the digestive process. Appl. Clay Sci. 20 (2001) 97-109
76. Torres-Ruíz J., López-Galindo A., González-López J.M., and Delgado A. Spanish fibrous clays: an approach to their geochemistry and micromorphology. In: López-Galindo A., and Rodríguez-García M.I. (Eds). Electron Microscopy. Materials Sciences vol. 92 (1992), Secr. Publ. Univ., Granda 595-596
77. US Pharmacopoeia 29-NF 24 (2006). US Pharmacopoeial Convention, Rockville, MD. Alumina and magnesium trisilicate oral suspension and tablets, 95-96; Activated attapulgite, 221; Colloidal activated attapulgite, 221-222; Kaolin, 1214; Magnesium trisilicate, 1303-1304; Magnesium trisilicate tablets, 1304; Talc, 2054-2056; Bentonite, 3278-3279; Purified bentonite, 3279-3280; Bentonite magma, 3280-3281; Magnesium aluminum silicate, 3362-3364.
78. In: Velde B. (Ed). Origin and Mineralogy of Clays: Clays and the Environment (1995), Springer, Berlin 334 pp.
79. Veniale F. Uses and applications of clays and clay minerals: state of-the-art and perspective. (Chairman lecture). Proc. 9th Int. Clay Conf. AIPEA, Strasbourg. Sci. Geol., Mem. 89 (1990) 81-90
80. Virta R.L. US Geological Survey mineral industry surveys. Clay and Shale - 2004 (2004). http://minerals.usgs.gov/minerals/pubs/commodity/clays/claysmyb04.pdf available at: http://minerals.usgs.gov/minerals/pubs/commodity/clays/claysmyb04.pdf
81. Viseras, C., 1997. Caracterización de distintos materiales de origen mineral para su empleo en la elaboración de medicamentos: esmectitas, paligorskitas, sepiolitas. Ph. D. Thesis, Univ. Granada. 250 pp and Annexes.
82. Viseras C., and López-Galindo A. Pharmaceutical applications of some Spanish clays (sepiolite, palygorskite, bentonite): some preformulation studies. Appl. Clay Sci. 14 (1999) 69-82
83. Viseras C., Aguzzi C., Cerezo P., and López-Galindo A. Uses of clay minerals in semisolid health care and therapeutic products. Appl. Clay Sci. 36 (2007) 37-50 10.1016/j.clay.2006.07.006 (this volume)
84. Viseras, C., Cultrone, G., Cerezo, P., Aguzzi, C., Baschini, M.T., Vallés, J., López-Galindo, A., in press. Characterization of Northern Patagonian bentonites for pharmaceutical uses. Appl. Clay Sci.
85. Wagner J.C., Griffiths D.M., and Munday D.E. Experimental studies with palygorskite dusts. Br. J. Ind. Med. 44 (1987) 749-763
86. Wagner J.C., Pooley F.D., Gibbs A., Lyons L., Sheers G., and Moncrieff C.B. Inhalation of china stone and clay dusts: relationship between the mineralogy of dust retained in the lungs and pathological changes. Thorax 41 (1996) 190-196
87. Weaver C.E., and Pollard L.D. The chemistry of clay minerals. Developments in Sedimentology vol. 15 (1973), Elsevier, Amsterdam 213 pp.
88. Wehner A.P. Cosmetic talc should not be listed as a carcinogen: comments on NTP's deliberations to list talc as a carcinogen. Regul. Toxicol. Pharmacol. 36 1 (2002) 40-50
89. In: Wenninger J.A., Canterbery R.C., and McEwen Jr. G.N. (Eds). International Cosmetic Ingredient Dictionary and Handbook. 8th ed. vol. 1-3 (2000), Toiletry and Fragance Association, Washington, DC
90. Yebra, A., 2000. Influencia de la mineralogía, quimismo y textura en las aplicaciones básicas industriales de la sepiolite. Ph.D Thesis, Universidad de Granada. 300 pp.
91. Yekeler M., Ulusoy U., and Hiçyilmaz C. Effect of particle shape and roughness of talc mineral ground by different mills on the wettability and floatability. Powder Technol. 140 1-2 (2004) 68-78
92. Zazenski R., Ashton W.H., Briggs D., Chudkowski M., Kelse J.W., MacEachern L., McCarthy E.F., Nordhauser M.A., Roddy M.T., Teetsel N.M., Wells B., and Gettings S.D. Talc: occurrence, characterization, and consumer applications. Regul. Toxicol. Pharmacol. 21 (1995) 218-229